Target intelligence / Profile preview

Nicotinic Acetylcholine Receptor (α1₂βγε Subtype) (nAChR α1₂βγε)

Target
nAChR α1₂βγε
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

The nicotinic acetylcholine receptor (nAChR) α1₂βγε subtype is a ligand-gated ion channel found at the neuromuscular junction of adult mammalian skeletal muscle. It is composed of two α1, one β, one γ, and one ε subunit. Upon binding of acetylcholine, the channel opens, allowing cations (Na+, K+, and Ca2+) to flow through the membrane, leading to muscle cell depolarization and contraction. This receptor is the primary target in autoimmune diseases like myasthenia gravis and is also targeted by neuromuscular blocking agents used in anesthesia.

Other names
Muscle-type Nicotinic Acetylcholine ReceptornAChR α12bgeAcetylcholine Receptor, Nicotinic, Muscle Subtype
02

Mechanism of action

Agonist-induced opening of ion channel, leading to cation influx and muscle cell depolarization.

03

Biological functions

Synaptic transmissionMuscle contractionIon transportNeuromuscular junction signaling
04

Disease associations

Myasthenia GravisLambert-Eaton myasthenic syndrome
05

Safety considerations

Muscle paralysisRespiratory failure (with excessive blockade)Cardiovascular effects (related to autonomic ganglia stimulation)
06

Interacting drugs

Acetylcholine

6 more in the full profile.

07

Biomarkers

Anti-AChR antibodies (Myasthenia Gravis)

Beyond the preview

Go deeper on Nicotinic Acetylcholine Receptor (α1₂βγε Subtype) (nAChR α1₂βγε).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic Acetylcholine Receptor (α1₂βγε Subtype) (nAChR α1₂βγε).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call